The state of Delaware currently has 2 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Newark, Wilmington, Lewes and Rehoboth Beach.
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
06/12/2025
Locations: Nephrology Associates PA, Newark, Delaware
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
Recruiting
An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.
Gender:
ALL
Ages:
30 years and above
Trial Updated:
06/16/2023
Locations: HealthCore, Inc., Wilmington, Delaware
Conditions: Diabetes Mellitus, Type 2